NCT02730429 Trial of Letrozole + Palbociclib/Placebo in Metastatic Endometrial Cancer Status COMPLETED Phase PHASE2
NCT02730091 A Open Study of Metronomic Oral Vinorelbine in Combination With Aromatase Inhibitors for the Treatment of Postmenopausal Women With Hormone Receptor Positive,HER2-negative, Advanced Breast Cancer Who Received no Prior Therapy for Advanced Disease Status TERMINATED Phase PHASE3
NCT02712723 Letrozole Plus Ribociclib or Placebo as Neo-adjuvant Therapy in ER-positive, HER2-negative Early Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02703649 Administration of Single High Dose Letrozole for Ovulation Induction Status COMPLETED Phase PHASE4
NCT02701348 Radiological and Biological Tumoural and Peri-tumoural Factors in Neoadjuvant Endocrine-treated Breast Cancers Status COMPLETED Phase NA
NCT02689921 NEOADjuvant Aromatase Inhibitor and Pertuzumab/Trastuzumab for Women With Breast Cancer Status UNKNOWN Phase PHASE2
NCT02684032 A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast Cancer Status COMPLETED Phase PHASE1
NCT02679755 Palbociclib In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR+, HER2- Advanced Breast Cancer Status COMPLETED Phase PHASE4
NCT02670304 Preventive Application of Letrozole Decrease Incidence of Early Onset of OHSS Status COMPLETED Phase PHASE4
NCT02657928 Ribociclib and Letrozole in Treating Patients With Relapsed ER Positive Ovarian, Fallopian Tube, Primary Peritoneal, or Endometrial Cancer Status COMPLETED Phase PHASE2
NCT02648477 Pembrolizumab and Doxorubicin Hydrochloride or Anti-Estrogen Therapy in Treating Patients With Triple-Negative or Hormone Receptor-Positive Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT02619669 Neoadjuvant Run-In Study With TAK-228 Followed by Letrozole/TAK-228 in Women With High-Risk ER+/HER2- Breast Cancer Status WITHDRAWN Phase PHASE1
NCT02619162 Nintedanib+Letrozole in Postmenopausal Women With Breast Cancer: Clinical Trial Safety and Pharmacodynamics Status COMPLETED Phase PHASE1
NCT02600923 Palbociclib Plus Letrozole For Postmenopausal Women With HR(+) HER2(-) Advanced Breast Cancer For Whom Letrozole Is Deemed Appropriate Status COMPLETED Phase PHASE3
NCT02585388 Addition of Aromatase at the Navelbine in Pretreated Metastatic Breast Cancer. Status TERMINATED Phase PHASE2
NCT02551367 Letrozole Versus Clomiphene Citrate for Ovulation Induction in Women With Poly Cystic Ovary Syndrome ( PCOS ) Status UNKNOWN Phase PHASE2